SEATTLE--(BUSINESS WIRE)--[Attorney Advertising] Keller Rohrback L.L.P. is investigating claims that a recent price hike for the drug Daraprim, a treatment for toxoplasmosis, caused worsening of infection for some patients due to lapses in treatment. On August 10, 2015, Turing Pharmaceuticals L.L.C. purchased the rights to market the drug Daraprim. Immediately following the purchase, the company raised the price per tablet from $13.50 to $750.00, allegedly causing some to miss prescribed medica
| < Prev | Next > |
|---|
